Drug Information Association Logo
« Back to Listing

Improving Investigative Site Selection Practices

Track:
Clinical Operations

Day & Time:
June 17, 1:30PM - 3:00PM (Pacific Standard Time)

Session Number:
255

Room Number:
3

Level:
Basic

Type:
Symposium

Title:
Improving Investigative Site Selection Practices

Chair(s):
Kenneth A. Getz, MBA
Director of Sponsored Research; Chairman, CISCRP
Tufts Center For the Study of Drug Development, United States

Description:
This symposium provides an overview of the changing global investigative site landscape and discusses new tools and approaches to improve and optimize site selection practices. Highlighted new approaches will include an assessment and discussion of metrics that are better able to predict successful investigative site performance and a detailed review of the characteristics and expected utility of a new investigator databank of more than 120,000 investigators worldwide.

Learning Objective(s):
Review data characterizing the changing global investigative site landscape; Assess site characteristics that are predictive of clinical trial performance; Discuss the attributes and anticipated value of Investigator Databank.

Presentation(s) & Speaker(s):
Anticipating Trends and Changes in the Fragmented Global Investigative Site Landscape
Kenneth A. Getz, MBA
Director of Sponsored Research; Chairman, CISCRP
Tufts Center For the Study of Drug Development, United States

Advancing a Data-Driven Foundation for Investigative Site and Country Selection Strategies
Shawn Phillip Tedman, MBA
Global Feasibility Manager
Quintiles Inc., United States

Investigator Databank Collaboration: A Global Platform for Precompetitive Sharing
Elisa F. Cascade, MBA
Vice President
DrugDev.org, United States